
Harnessing CRISPR to Cure Infectious Diseases
Update: 2023-02-01
Share
Description
Daniel Dornbusch, CEO of Excision BioTherapeutics, sits down with Neil to discuss his company’s efforts to develop CRISPR-based therapies to cure HIV and other viral infectious diseases.
Comments
In Channel






















